Schidlow DN, Tworetzky W, Wilkins-Haug LE.
Am J Perinatol. 2014 Aug;31(7):629-36. doi: 10.1055/s-0034-1383884. Epub 2014 Jun 12.
PMID: 24922056 [PubMed – in process]
Select item 24858853
Comment from Dr. Mehul Patel, editor of Congenital Heart Journal Watch: This review summaries the utility of percutaneous FCI in:
(1) Aortic stenosis with evolving hypoplastic left heart syndrome, for which aortic valvuloplasty may prevent left ventricular hypoplasia and has yielded a biventricular circulation in approximately one third of cases.
(2) Hypoplastic left heart syndrome with intact atrial septum, for which relief of atrial restriction has potential to improve perinatal survival; and
(3) Pulmonary atresia with intact ventricular septum and evolving right ventricular hypoplasia, for which pulmonary valvuloplasty has resulted in a biventricular circulation in the majority of patients. The pathophysiology, rationale for intervention, patient selection criteria, procedural technique, outcomes and complications for each lesion is reviewed.